|
|
 |
|
Viewing report
|
|
|
|
Cardiotoxicity of Non-Cardiovascular Drugs
John Wiley and Sons Ltd, April 2010, Pages: 360
Some drugs which are not aimed at treating heart disease have nevertheless been found to have profound effects on heart muscle. Cardiotoxicity is one of the major forms of toxicity seen in drugs and it accounts for most drug recalls and delays experienced in regulatory approvals.In recent years a number of non-cardiac blockbuster drugs such as terfenadine have been withdrawn from major markets because of cardiotoxicity concerns, while other drugs have either been withdrawn prior to marketing or required labelling changes that significantly restricted their use.
In Cardiotoxicity of Non-Cardiovascular Drugs international experts describe the molecular mechanisms and clinical read-outs of cardiac events induced by a broad variety of noncardiovascular drugs. Particular emphasis isbe paid to the preclinical screening of drug cardiotoxicity.
Topics include:
- metabolic targets of cardiotoxicity
- regulatory aspects
- translating molecular mechanisms into clinical trials
- structure-activity relationships in arrhythmias by antihistamines and psychoactive drugs
- cardiovascular toxicity of antitumor drugs
- cardiovascular toxicities of non-steroidal anti-inflammatory drugs
- cardiovascular toxicities of antiretroviral therapies
Cardiotoxicity of Non-Cardiovascular Drugs is an essential guide to this important area of drug development. It will find a place on the bookshelves of researchers, regulators and students in medicinal chemistry, drug development, pharmacology, pharmacy and cardiovascular disease.
Product samples
A sample for this product is available. Please Login/Register to download this sample.
Customers who bought this item also bought
Cardiovascular Drug Delivery - Technologies, Markets and Companies
Cardiac Toxicity
Personalized Medicine - Scientific and Commercial Aspects
Comprehensive Toxicology. Edition No. 2
Pain Therapeutics - Drugs, Markets and Companies
Drug Delivery in Cancer - Technologies, Markets and Companies
Therapeutic Drug Monitoring - Technologies, Markets, and Companies
Alzheimer Disease - New Drugs, Markets and Companies
Cardiovascular Medicine: Review and Update for the Practitioner
Transdermal Drug Delivery - Technologies, Markets, and Companies
|
|
|
|
